DISCLOSEDQuarterly
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,844,930 sh · $849.4M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$1.87B
22,738,349 sh
Dodge & Cox
13F filer
$849.4M
14,844,930 sh
Viking Global Investors
13F filer
$435.8M
7,616,563 sh
Renaissance Technologies
13F filer
$57.9M
1,024,871 sh
Bridgewater Associates
13F filer
$11.7M
206,911 sh
Two Sigma Investments
13F filer
$2.5M
44,475 sh
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,844,930 sh · $849.4M
Viking Global Investors
Biomarin Pharmaceutical Inc · NASDAQ
7,616,563 sh · $435.8M
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,561,759 sh · $822.6M
Two Sigma Investments
Biomarin Pharmaceutical Inc · NASDAQ
44,475 sh · $2.5M
Bridgewater Associates
Biomarin Pharmaceutical Inc · NASDAQ
206,911 sh · $11.7M
Renaissance Technologies
Biomarin Pharmaceutical Inc · NASDAQ
1,024,871 sh · $57.9M
Viking Global Investors
Biomarin Pharmaceutical Inc · NASDAQ
7,062,077 sh · $398.9M
Renaissance Technologies
Biomarin Pharmaceutical Inc · NASDAQ
1,324,971 sh · $78.7M
Dodge & Cox
Biomarin Pharmaceutical Inc · NASDAQ
14,572,384 sh · $866.0M
Viking Global Investors
Biomarin Pharmaceutical Inc · NASDAQ
6,036,936 sh · $358.8M